Answers are grounded in this paper and cite their sources.
Retrospective cohort study finds increased risk of acute kidney injury during autologous stem cell transplantation in patients with chronic kidney disease, suggesting the need for careful management.
e19109 Background: Chronic kidney disease (CKD) may increase transplant-related toxicity during autologous stem cell transplantation (autoSCT) for diffuse large B-cell lymphoma (DLBCL). Contemporary national inpatient outcomes data for this subgroup are limited. Methods: We performed a retrospective cohort study using the 2022 National Inpatient Sample (NIS), which includes ~20% of U.S. hospital discharges. Adults (≥18 years) hospitalized with DLBCL who underwent bone marrow transplant/autoSCT were identified using ICD-10-CM/PCS codes and stratified by secondary diagnosis of CKD. Multivariable logistic regression was used for categorical outcomes and linear regression for continuous outcomes (length of stay [LOS], total hospitalization charges), adjusting for age, sex, race, Elixhauser comorbidity score, insurance status, and hospital characteristics. Results: We identified 1,025 DLBCL autoSCT hospitalizations; 80 (7.8%) had CKD. Mean age was 59.8 vs 58.6 years (p=0.63) and 68.8% vs 52.4% were male (p=0.21) in the CKD vs non-CKD cohorts. CKD was independently associated with higher AKI (56.25% vs 11.11%; adjusted OR [aOR] 8.48, 95% CI 1.88–38.1; p=0.005). Differences were not statistically significant for AKI requiring HD (6.25% vs 1.59%; aOR 4.76, 95% CI 0.41–55.2; p=0.21), septic shock (6.25% vs 3.70%; aOR 3.92, 95% CI 0.44–34.9; p=0.22), in-hospital mortality (6.25% vs 4.23%; aOR 1.41, 95% CI 0.20–9.7; p=0.72), or intubation (6.25% vs 1.40%; aOR 0.32, 95% CI 0.04–2.07; p=0.23). Mean total charges were $100,488 lower and mean LOS 2.9 days shorter in the CKD cohort versus non-CKD; however, neither difference was statistically significant. Conclusions: In a national inpatient cohort of DLBCL hospitalizations undergoing autoSCT, pre-existing CKD was independently associated with a markedly higher risk of AKI, highlighting renal vulnerability during transplant admission. In contrast, differences in AKI requiring HD, septic shock, intubation, LOS, charges, and in-hospital mortality were not statistically significant after adjustment. Taken together, these findings emphasize the need for heightened vigilance for AKI in high-risk patients with CKD. It supports proactive peri-transplant renal risk mitigation, including optimizing fluid management and medication review to minimize AKI development.
No takes yet. Share an insight, caveat, or question.
Patel et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: